BioRestorative Therapies Inc. logo

BioRestorative Therapies Inc.

BRTX | NASDAQ
Chart Builder DCF Calculator
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.71
$0 (+0.02%)
Pre-market: Sep 22, 2026, 9:16 AM ET

Market Data

Market Cap
$3.74M
Enterprise Value
$185.34K
Beta
0.74
Average Volume
46.3K
Shares Outstanding (Diluted)
886.39K
Shares Change YoY
112.13%
Institutional Ownership
4.34%
Exchange
NASDAQ
ISIN
US0906556065

Price Performance

Price Change 1M
-38.0%
Price Change 3M
-64.7%
Price Change 6M
-56.3%
Price Change YTD
-88.9%
Price Change 1Y
-90.8%
Price Change 3Y
-91.8%
Price Change 5Y
-99.0%
1M CAGR (ann.)
-33.6%
1Y CAGR (ann.)
-90.7%
5Y CAGR (ann.)
-60.5%
All-Time CAGR
-63.1%

Valuation

PE Ratio
-0.12
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
0.01
PS Ratio
10.46
Forward PS
1.20
PB Ratio
1.24
P/FCF Ratio
-0.31
P/Adj. FCF Ratio
-0.28
P/OCF Ratio
-0.20
EV/Sales
0.52
EV/EBIT
-0.02
EV/EBITDA
-0.02
EV/FCF
-0.02
Earnings Yield
-819.2%
FCF Yield
-317.9%
Adj. FCF Yield
-360.8%

Financial Health

Net Cash
$3.56M
Total Debt
$34.52K
Cash & Short-Term Investments
$3.59M
Total Assets
$4.64M
Current Ratio
2.35
Quick Ratio
2.35
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
-342.40
Interest Coverage
0.00
Altman Z-Score
-57.75
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
92.1%
Operating Profit Margin
-3975.0%
EBITDA Margin
-3030.7%
Net Profit Margin
-3089.6%
FCF Margin
-3324.6%
Adj. FCF Margin
-3773.5%
SBC / Revenue
449.0%
SBC Impact (per share)
-13.5%

Returns

Return on Assets
-238.3%
Return on Equity
-423.8%
Return on Invested Capital
-464.9%
Return on Capital Employed
-470.2%
Return on Tangible Assets
-267.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
38.4%
Revenue CAGR 5Y
39.0%
Revenue CAGR 10Y
-2.3%
EPS CAGR 3Y
2.0%
EPS CAGR 5Y
68.3%
EPS CAGR 10Y
41.1%
FCF CAGR 3Y
-28.6%
FCF CAGR 5Y
-22.1%
FCF CAGR 10Y
-11.1%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
21.9%
Revenue Growth Next 3Y
125.9%
Earnings Date
Sep 21, 2026
EPS Estimate (next Q)
-$2
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$600K
Revenue Growth Est (next Q)
97.8%

Cash Flow

Operating Cash Flow
$-11.82M
Free Cash Flow
$-11.9M
Adj. Free Cash Flow
$-13.5M
FCF Per Share
-$13.42
OCF Per Share
-$13.33
OCF/S Ratio
-3302.3%

Income Statement

Revenue
$357.87K
Gross Profit
$329.55K
Operating Income
$-14.23M
EBITDA
$-10.85M
Net Income
$-11.06M
EPS (Diluted)
-$22.20
Revenue / Employee
$32.53K
Profit / Employee
$-1.01M
Employees
11

© 2026 bestshares.com. All rights reserved.